We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

151 hedge funds and large institutions have $299M invested in Definium Therapeutics in 2024 Q2 according to their latest regulatory filings, with 44 funds opening new positions, 39 increasing their positions, 24 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

282% more call options, than puts

Call options by funds: $14.4M | Put options by funds: $3.77M

63% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 27

63% more repeat investments, than reductions

Existing positions increased: 39 | Existing positions reduced: 24

12% more funds holding

Funds holding: 135 → 151 (+16)

9% less capital invested

Capital invested by funds: $327M → $299M (-$28.2M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

26.45% less ownership

Funds ownership: 84.24% → 57.79% (-26%)

Holders
151
Holders Change
+16
Holders Change %
+11.85%
% of All Funds
2.18%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.04%
New
44
Increased
39
Reduced
24
Closed
27
Calls
$14.4M
Puts
$3.77M
Net Calls
+$10.6M
Net Calls Change
-$11.6M

Top Buyers

1
BlackRock
BlackRock
New York
+$40.1M
2
State Street
State Street
Massachusetts
+$14.7M
3
CC
Commodore Capital
New York
+$11.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$10.3M
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$9.84M

Top Sellers

1
GPP
Great Point Partners
Connecticut
-$18.8M
2
Janus Henderson Group
Janus Henderson Group
United Kingdom
-$8.11M
3
SCM
Soleus Capital Management
Connecticut
-$7.05M
4
DTC
Deep Track Capital
Connecticut
-$4.92M
5
Millennium Management
Millennium Management
New York
-$3.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
CC
1
Commodore Capital
New York
$51.5M +$11.5M +1,312,555 +23%
DTC
2
Deep Track Capital
Connecticut
$44M -$4.92M -562,850 -8%
BlackRock
3
BlackRock
New York
$38.8M +$40.1M +4,589,718 +578%
DCM
4
Driehaus Capital Management
Illinois
$18.3M -$79.9K -9,135 -0.4%
Marshall Wace
5
Marshall Wace
United Kingdom
$15.6M +$1.41M +161,659 +8%
OCA
6
Octagon Capital Advisors
New York
$15.5M – – –
Blackstone Inc
7
Blackstone Inc
New York
$13.7M +$5.67M +648,450 +52%
State Street
8
State Street
Massachusetts
$13M +$14.7M +1,686,143 +1,418%
Vanguard Group
9
Vanguard Group
Pennsylvania
$12.6M +$10.3M +1,178,482 +209%
Geode Capital Management
10
Geode Capital Management
Massachusetts
$10.9M +$9.84M +1,125,365 +289%
AG
11
Artal Group
Luxembourg
$7.27M +$8.81M +1,007,875 New
WP
12
Woodline Partners
California
$7.22M +$5.87K +671 +0.1%
ABG
13
Ally Bridge Group
New York
$6.96M -$315K -36,026 -4%
AIC
14
AWM Investment Company
New York
$6.01M – – –
Two Sigma Investments
15
Two Sigma Investments
New York
$4.93M -$250K -28,551 -4%
Charles Schwab
16
Charles Schwab
California
$4.01M +$3.14M +359,143 +182%
TLP
17
Tri Locum Partners
New York
$2.75M +$21.5K +2,459 +0.6%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$1.78M +$1.78M +203,216 +473%
N
19
Nuveen
North Carolina
$1.47M +$1.79M +204,140 New
Northern Trust
20
Northern Trust
Illinois
$1.33M +$1.04M +118,365 +181%
IC
21
Ikarian Capital
Texas
$1.17M -$1.18M -135,000 -45%
Morgan Stanley
22
Morgan Stanley
New York
$1.14M +$411K +47,019 +42%
MSAM
23
Moloney Securities Asset Management
Missouri
$976K -$233K -26,650 -16%
AI
24
AdvisorShares Investments
Maryland
$878K +$128K +14,659 +13%
Swiss National Bank
25
Swiss National Bank
Switzerland
$800K +$970K +110,900 New
1
2 3 4 5

DFTX Hedge Fund Activity: Q2 2024 in Review

151 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q2 2024, worth a combined $299M — down 8.6% from $327M a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new DFTX positions and 27 closed out — a net gain of 17 holders — while 39 added to existing stakes and 24 trimmed.

The largest buyer was BlackRock, adding an estimated $40.1M. The largest seller was Great Point Partners, exiting entirely with an estimated $18.8M sold.

  • 151 institutional investors held Definium Therapeutics (DFTX) as of Q2 2024, up from 135 in Q1 2024.
  • Funds reported $299M of Definium Therapeutics stock for Q2 2024, down 8.6% quarter-over-quarter.
  • 44 funds opened new Definium Therapeutics positions in Q2 2024 and 27 closed out, a net change of +17 holders.
  • The largest Definium Therapeutics buyer in Q2 2024 was BlackRock, an estimated $40.1M added.
  • The largest Definium Therapeutics seller in Q2 2024 was Great Point Partners, an estimated $18.8M sold.

Based on aggregated 13F filings for Q2 2024.